glp 1 receptor agonist agent GLP-1 Agonists and Research to Treat Overeating and Substance Use Disorders New Molecules and Emerging Indications
Description
Learn how SmithRx helps optimize pharmacy spend while supporting member health.
Individual results may vary
This product is not intended to diagnose, treat, cure, or prevent any disease
AstraZeneca, Novo Nordisk A/S, Eli Lilly and Company, Sanofi and Hypera S.A
2023 brought with it many medical advances, including the "skinny shot" for weight loss, known in its various formulations as the brand names Ozempic, Wegovy, Mounjaro and others
